News and information
Hopkins China biomedical research and development innovation BBS is held in Beijing
On October 17, 2015, China biological medicine r&d innovation BBS and international technology transfer, project and capital docking exchange meeting was held in Beijing hotel. This BBS is jointly sponsored by the ministry of human resources and social security, the service center for overseas students and experts, the China service alliance for overseas students returning to China, the sino-us international technology transfer center for biological medicine, and the Beijing overseas high-level talent association. By tonghua national medicine high-tech industrial development zone, China hi-tech investment group Co., Ltd., Beijing science and technology park construction (group) Co., Ltd., keeping investment group, h&q investment group, Sealand Securities Co., Ltd., a division of China merchants investment management group Co., Ltd and chinaequity capital group, zhongguancun u.s.-china biotechnology industry cluster innovation alliance, founded united (Beijing) human resource management center, henan overseas students pioneer park, changchun overseas students pioneer park, and a number of institutions in zhuhai overseas students pioneer park. More than 60 media, including xinhua news agency, China news service, People's Daily, xinhuanet, world manager's website, and management experts, attended the conference.
Ding xuefeng, a well-known management expert, deputy director of the management modernization committee of China enterprise confederation, and author of the best-selling book "light management: the real secret of making management simple" and "light management practice: four keys of making management subtraction", served as the host and introduced the guests.
First director of the Chinese students studying abroad to return service alliance "as the general assembly for a speech, and introduces the Chinese students studying abroad to return service alliance, it is known that Chinese students studying abroad to return service alliance is committed to improve the students studying abroad to return service cooperation mechanism, strengthen the coordination between different service members, promote services between alliance members in the preparation of student talent introduction plan, the implementation of key projects, the implementation of the important policies, strengthen communication and coordination, and jointly create a harmonious service environment. Then "in the growth, director of Johns Hopkins hospital research institute are introduced and mainly put forward Zhao Baisong dean as a club of Chinese students studying abroad to return business expert guidance committee mentors, by holding this BBS, vigorously promote the overseas outstanding projects and investment institutions good docking, for Zhao Baisong dean's contribution to give higher for sure.
Then the European and American society enterprise association Xu Changdong published a speech, the President of Xu Changdong, current European and American society entrepreneurs association President, the clean energy BBS, chairman of China, China's general aviation development association, association of Chinese helicopter industry development, low industrial economy research institute of China, social position, such as, chairman of the China holiday union President says Hopkins medical institute adhering to the "introduction, digestion, absorption, application, innovation" concept of development, will be promising in the field of biological medicine, and the BBS of "technology transfer and capital docking" issues, is bound to cause a new wave of biological medicine industry, As executive chairman of the world angel investment conference, the President said he would also closely monitor and support the development of the Hopkins medicine institute.
The ministry of civil affairs, enterprise citizen committee, vice President of China and director-general wei-hua liu congratulations on BBS successfully convened, hope the guests by taking part in "China biological medicine research and development innovation BBS and international technology transfer, project docking with the capital exchange", can attract more biological pharmaceutical companies, investment and financing enterprises and scientific research of biomedical technology at home and abroad and biological industry forefront academic fields and project capital docking problem deeply concerned, creating a harmonious atmosphere of enterprise development, the combination of projects and funds, complementary advantages, let more Chinese enterprises focus on pharmaceutical r&d and innovation, and promote the innovation and development of biological medicine industry in China.
Next, zhao feng, former deputy director of the Beijing overseas scholars center, gave a speech and first congratulated BBS on its success. Zhao said that some high-tech talents chose to return to China to start their own businesses through training abroad, which promoted the economic development of China. Some experts in the field of biology returned to China to start their own businesses and achieved great success, which greatly promoted the development of the biomedical industry. The BBS sponsored by Hopkins medicine research institute attracted guests from all parties in the industry to participate, and set up a very good platform for biomedical enterprises and venture capital companies. We hope BBS will continue to develop better and make contributions to the development of China's biomedical industry.
Cheng yong, vice President of hengrui group, from his own perspective, Mr. Chen first congratulated BBS on its success. Hengrui group is a comprehensive group that invests in overseas real estate, real estate, finance, fund and trust in the United States and other north American regions. We have good cooperation with wanda group and Greenland group in China. In 2016, we plan to invest 100 million us dollars in biomedical investment. We hope to cooperate with biomedical enterprises to help them develop and make due contributions.
BBS is mainly divided into three parts. The first part is expert speech and policy publicity.
First, du rentang, deputy general manager of China hi-tech investment group co., LTD., gave a speech on the development of biomedicine from the perspective of investment.
Then, li beiwei, an expert, consultant, professor and tutor of the ministry of science and technology made the keynote speech of "accelerating the cultivation of biomedical industry to provide services for the transformation and upgrading of the pharmaceutical industry".
(photo shows li beiwei, an expert, consultant, professor and tutor of the ministry of science and technology.)
LAN LAN, deputy general manager of beikejian asset management (Beijing) co., LTD., delivered a keynote speech on "development and construction of biological medicine industrial park and development of biological medicine industry".
Later, li xiaoming, chairman of handing investment group LP and shenzhen jiuan fuying investment group, gave a speech on "the new third board equity transfer system to boost the rapid development of innovative enterprises".
Qiao hongbo, chairman of hai rong investment group, delivered the keynote speech of "hai rong capital and overseas returnees' entrepreneurship".
Next is wang ying, technology center of Harbin pharmaceutical group, who delivered a keynote speech titled "the transformation and upgrading of pharmaceutical enterprises must draw on the strength of international pharmaceutical innovation team".
Liu bin, deputy director of zhuhai municipal people's and social security bureau, delivered a speech on "promoting the development of zhuhai biomedical industry with international high-end talent team".
Hu bo, chairman of the party committee of ciming health and physical examination group, delivered the keynote speech of "ciming model promoting the sustainable development of China's economy under the new medical industry".
Haidian technology and financial capital holding group vice President, zhongguancun biomedical park chairman liu glory "biomedical innovation support system" keynote speech.
Next, zhao baisong, President of Hopkins medicine research institute and tutor of overseas students in the department of human resources and social security, made the theme speech of "analyzing the opportunities and challenges of the development of China's biomedical industry from an international perspective".
Li zhiliang, chairman of auda international biotechnology (Beijing) co., LTD and an expert of national plan for thousand talents, delivered a keynote speech on the development trend and market orientation of international biomedical industry.
The second link is the biological medicine project road shows and biological medicine research and development results release, this well-known management expert, link, deputy director of the China enterprise confederation management modernization effort, best-selling "light management: let the real secrets of management is very simple, and the light field management: four key for management to do subtraction, such as book author Dr Xue-feng ding.
First, a project roadshow of "China's first breakthrough in 3D printed holographic reconstruction and clinical application" was conducted by zhang jianqing of henan longguang 3D biological engineering co., LTD.
Ji qi, chemical director of Beijing fulong kangtai biotechnology co., ltd. conducted the road show of "fp-208 project of anti-tumor targeted therapy".
The third one is the "immune anti-tumor method" project roadshow conducted by Beijing ruibai biotechnology co., LTD.
Fourth, li feng, deputy general manager of Hopkins (Beijing) medical diagnostic technology co., LTD., conducted the road show of "innovative diagnostic reagent project with independent intellectual property rights".
The fifth, sun jianjun, President of Beijing jujing ruisheng medical technology co., LTD., conducted a road show of "innovative surgical instruments and medical consumables condensed from clinical practice".
Next, Dr. Liu tianhe, director of antibody drug project of Hopkins medical research institute, conducted the road show of "pd-1 + other antibodies, pd-1, car-t, i-car, i-do cancer immunotherapy".
Then, Dr. Wang huiru, a senior researcher at the Hopkins medical research institute, introduced "the most advanced car-t immunotherapy technology in the world".
At last, Dr. Leng qiang, executive vice President of Hopkins medicine research institute, introduced the "super-capacity full-human antibody library" and "high-throughput drug screening platform".
The third part is the project cooperation signing ceremony. The director of jilin qijian biotechnology co., ltd. and teng honggang, President of Hopkins (changchun) medical research institute, signed the "anti-tumor pd-1 (BMS) cancer immunotherapy drug industrialization project" on the stage.
The project of "joint establishment of Hopkins biological medicine and translational medicine research and development center" was signed by zhang jian, director of siping economic development zone and teng honggang, President of Hopkins (changchun) medical research institute.
Li zhiliang, CEO of China and America oda biotechnology (Beijing) co., ltd. signed the "anti-tumor pd-1 (MERCK) cancer immunotherapy drug industrialization project" together with zhao baisong, President of the Hopkins medicine research institute and an entrepreneurial tutor of overseas students in the department of human resources and social security.
Qiao hongbo, chairman of hairong capital management co., LTD., signed the "strategic cooperation agreement between the overseas returnees' entrepreneurial team and the overseas returnees' financing capital" with zhao baisong, chairman of the Hopkins medical research institute and the entrepreneurial tutor of overseas students in the ministry of human resources and social security.
Ciming health and physical examination group, President of the Hopkins medicine research institute, and zhao baisong, entrepreneurial tutor of overseas students in the department of human resources and social security signed the "cooperation and co-construction of international health and medical service innovation technology industry alliance".
Finally, BBB 1 was successfully delivered by BBB 0's executive chairman, Dr Zhao baisong.
(photo taken from left to right: Lu Daming, President of China and the United States by the People's Daily Li Zhiliang, chief executive of biological technology (Beijing) co., LTD., ministry of science and technology experts and consultants, professor, PhD supervisor Li Beiwei, zhuhai people club bureau deputy director liu bin, siping zhang jian, director of the economic development zone, Hopkins medicine research institute chairman, people club department student mentors Zhao Baisong, the ministry of civil affairs, enterprise citizen committee, vice President of China and director-general wei-hua liu, Johns Hopkins medical institute Taiwan branch director Hou Junjian, former director of the Beijing overseas scholars center zhao, the author of the "light management field", xue-feng ding, ciming health check-up, head of the group, henan Long Guang director 3-d biological engineering co., LTD Zhang jianqing